Antibiotic

Erythromycin is a macrolide antibiotic that targets bacterial 50S ribosomal subunits, effectively inhibiting RNA-dependent protein synthesis by obstructing transpeptidation and translocation reactions. This compound demonstrates a broad spectrum of antimicrobial activity against various bacteria, making it valuable in microbiological research. Additionally, erythromycin has been shown to possess antitumor and neuroprotective properties, contributing to its usefulness in diverse areas of biomedical research.

Tetracycline is a broad-spectrum antibiotic that targets bacterial protein synthesis by binding to the 30S ribosomal subunit, inhibiting translation. It demonstrates activity against a diverse array of microorganisms, including gram-positive and gram-negative bacteria, as well as chlamydiae, mycoplasmas, and rickettsiae. This compound is widely utilized in research related to bacterial infections and antibiotic resistance mechanisms.

Acetoxycycloheximide is an antibiotic with potent antitumor properties, primarily functioning as a protein synthesis inhibitor. It effectively induces procaspase-3 activation, leading to apoptosis through the release of cytochrome c from mitochondria via the JNK signaling pathway. Additionally, acetoxycycloheximide downregulates cell surface TNF-R1 by activating the ERK and p38 MAPK pathways, thereby inhibiting TNF-α-mediated NF-κB signaling. This reagent is valuable for research related to inflammatory and immune diseases as well as cancer.

Metronidazole hydrochloride is a nitroimidazole antibiotic with a primary mechanism of action against anaerobic bacteria. It is effective in the treatment of various anaerobic infections and possesses the ability to penetrate the blood-brain barrier. Research applications include studying its effects on inflammation and skeletal muscle contraction associated with long-term use.

Monensin, a polyether antibiotic, functions primarily as an ionophore that mediates Na+/H+ exchange. It has been identified as a potent inhibitor of Wnt signaling, leading to significant enlargement of multivesicular bodies (MVBs) and modulating exosome secretion. This compound is utilized in research focused on bacterial, fungal, and parasitic infections, and it also exhibits anticancer properties, making it a valuable tool in various biological studies.

Siomycin A is a thiopeptide antibiotic that selectively inhibits Forkhead box M1 (FOXM1), while sparing other Forkhead box family members. It exhibits significant anti-tumor activity and promotes apoptosis, making it a valuable tool for cancer research. This compound is particularly useful for studies focused on the role of FOXM1 in tumorigenesis and therapeutic resistance.

Terrein is an antibiotic that functions as a melanogenesis inhibitor. It induces apoptosis in breast cancer cell lines and acts as an inhibitor of quorum sensing and cyclic di-GMP levels in Pseudomonas aeruginosa. This compound is valuable in studying mechanisms of cancer cell regulation and bacterial communication processes.

Bleomycin A5 (hydrochloride) is a glycopeptide antibiotic that primarily functions as a DNA inhibitor. This compound exerts its cytotoxic effects by chelating Fe2+, which leads to the formation of reactive species that induce both single-strand and double-strand breaks in DNA, thereby disrupting DNA replication. Additionally, Bleomycin A5 (hydrochloride) inhibits Drp1-mediated mitochondrial fission and modulates the PINK1/Parkin pathway, contributing to mitochondria-mediated apoptosis. It is widely utilized in cancer research applications.

Actinonin is a naturally occurring antibiotic that functions primarily as an aminopeptidase N inhibitor. It exhibits potent antimicrobial activity and acts as a reversible peptide deformylase (PDF) inhibitor with a Ki value of 0.28 nM. Additionally, Actinonin shows inhibitory effects on matrix metalloproteinases MMP-1, MMP-3, MMP-8, and MMP-9, with respective Ki values of 300 nM, 1,700 nM, 190 nM, and 330 nM. It also possesses pro-apoptotic properties and has demonstrated antiproliferative and antitumor activities, making it a valuable tool for cancer research and therapeutic exploration.

Bleomycin A5 is a glycopeptide antibiotic that exerts cytotoxic effects primarily through its interaction with Fe2+, leading to the formation of a complex that induces both single-strand and double-strand DNA breaks, while inhibiting DNA replication. Additionally, it targets Drp1-mediated mitochondrial fission and suppresses the PINK1/Parkin pathway-mediated mitophagy, ultimately promoting mitochondria-mediated cellular apoptosis. This compound is valuable in cancer research, particularly in studies focused on mechanisms of apoptosis and DNA damage responses.

Chrysomycin A is an antibiotic derived from the Streptomyces genus. It demonstrates significant antitumor properties, alongside effective activity against Mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus (MRSA). In glioblastoma research, Chrysomycin A has been shown to inhibit cancer cell proliferation, migration, and invasion by targeting the Akt/GSK-3β/β-catenin signaling pathway, making it a valuable tool for cancer studies and antibiotic research.

Ceftiofur sodium is an antibiotic that acts as a cell wall synthesis inhibitor by targeting bacterial penicillin-binding proteins (PBPs). It exhibits bactericidal activity through the inhibition of peptidoglycan synthesis, resulting in bacterial cell lysis. Additionally, Ceftiofur sodium has anti-inflammatory properties by inhibiting the activation of NF-κB and MAPKs, which decreases the secretion of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. This compound is applicable in research related to antibiotic resistance and inflammatory responses.

Cefaclor monohydrate is an orally active cephalosporin antibiotic that targets penicillin-binding protein 3 (PBP3). It is effective against a variety of bacterial infections, including respiratory tract infections, bacterial bronchitis, pharyngitis, and skin infections. Additionally, Cefaclor has potential applications in research related to depression and other bacterial pathologies.

Erythromycin Ethylsuccinate is an antibiotic that primarily targets bacterial infections by inhibiting protein synthesis in susceptible microorganisms. It demonstrates an antimicrobial spectrum that is comparable to, or slightly broader than, that of penicillin, making it effective against a variety of Gram-positive and some Gram-negative bacteria. Additionally, Erythromycin Ethylsuccinate exhibits antiviral activity against HIV-1, providing a versatile option for researchers studying bacterial and viral pathogens. Its applications include exploring antimicrobial resistance and developing new therapeutic strategies.

Oxolinic acid is an antibiotic effective against both Gram-negative and Gram-positive bacteria. It is primarily utilized in research focused on acute and chronic urinary tract infections. Additionally, Oxolinic acid functions as a DNA/RNA synthesis inhibitor and acts as a dopamine uptake inhibitor, demonstrating stimulatory effects on locomotor activity in murine models.

Pefloxacin mesylate dihydrate is a broad-spectrum antibiotic that primarily inhibits DNA gyrase, disrupting DNA replication. This compound demonstrates significant antibacterial activity against both Escherichia coli and Pseudomonas aeruginosa, with MIC90 values of 0.12 mg/L and 4 mg/L, respectively, and also targets Bacteroides fragilis with an MIC90 of 16 mg/L. Additionally, Pefloxacin mesylate dihydrate exhibits anti-Plasmodium yoelii activity and can enhance UVA-induced edema and immunosuppression. Its diverse profile makes it a valuable tool for infection studies and related research applications.

Succinylsulfathiazole is a sulfonamide antibiotic that targets bacterial folate synthesis, providing localized, gut-specific antibacterial activity. This compound effectively reduces coliform counts, suppresses intestinal bacterial growth, and depletes gut folate-producing bacteria while modulating hepatic mTOR signaling. Succinylsulfathiazole is utilized in research focused on nutrient deficiency and its implications, as it induces folate deficiency and related nutritional symptoms in animal models such as rats and C57BL/6 mice. This antibiotic is valuable for understanding the mechanisms of gut flora modulation and the impact on nutritional status.

Rifamycin sodium is an orally active ansamycin antibiotic that inhibits DNA-dependent RNA synthesis. It demonstrates significant antibacterial activity against Mycobacterium tuberculosis and modulates hepatic bile acid metabolism. Additionally, Rifamycin sodium exhibits anti-inflammatory properties, making it valuable for studying Mycobacterium tuberculosis, Bacteroides fragilis infections, and inflammation induced by lipopolysaccharides.

Erythromycin thiocyanate is a macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit, effectively inhibiting RNA-dependent protein synthesis through interference with transpeptidation and translocation processes. This compound exhibits broad-spectrum antimicrobial activity, making it valuable in research applications related to bacterial infections. Additionally, erythromycin thiocyanate has been shown to possess antitumor and neuroprotective properties, expanding its potential utility across various biomedical research fields.

Lomefloxacin is a difluoroquinolone antibiotic that primarily targets bacterial topoisomerase II, inhibiting DNA supercoiling and replication. This compound exhibits broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria and is effective in inducing reactive oxygen species (ROS) production and apoptosis. Additionally, Lomefloxacin demonstrates promising anticancer efficacy against melanoma, making it a valuable tool for research applications involving systemic bacterial infections and skin cancer studies.

Bafilomycin C1 is a macrolide antibiotic that functions as a specific and reversible inhibitor of vacuolar-type H+-ATPases (V-ATPases). It exhibits potent antibacterial and antifungal activity, particularly against gram-positive organisms. Additionally, Bafilomycin C1 has been shown to induce apoptosis, making it a valuable tool for research into hepatocellular carcinoma (HCC) and related cellular processes.

Roridin E is an antibiotic that exhibits cell-inhibiting and fungicidal properties. It is known for its efficacy in combating various fungal infections and serves as a valuable tool in antimicrobial research. Roridin E's mechanism of action, which involves disrupting cellular processes in target organisms, makes it suitable for studies aimed at understanding fungal pathogenesis and potential therapeutic interventions.

Candicidin is a polyene antifungal antibiotic agent that functions by binding to ergosterol in fungal cell membranes, leading to increased permeability and cell death. It exhibits potent antifungal activity against a range of pathogenic fungi. Candicidin is primarily used in research applications focused on fungal infections and the mechanisms of antifungal resistance.

Polyhexamethyleneguanidine hydrochloride is a cationic polymer known for its broad-spectrum antimicrobial activity. It primarily exerts its antibacterial effects by interacting with bacterial and fungal cell membranes, leading to disruption of membrane integrity. This compound is valuable in research related to disinfection, water treatment, and agricultural pesticides.

Pyrrolnitrin is an antibiotic derived from Pseudomonas pyrrocinia, demonstrating potent activity against a wide range of fungal pathogens, yeast, and gram-positive bacteria. This compound is utilized extensively in research to explore antimicrobial mechanisms and develop therapeutic strategies against resistant infections. Its broad-spectrum effectiveness makes it a valuable tool in microbiological studies and antibiotic susceptibility testing.

Piperlonguminine is an alkaloid amide derived from Piper species, exhibiting significant antibacterial properties. Furthermore, it demonstrates a range of biological activities, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, and antifungal effects. This compound is of interest in various research applications, particularly in the fields of pharmaceutical development and disease prevention.

Tyrothricin is a polypeptide antibiotic mixture derived from Bacillus brevis, comprising tyrocidines and gramicidins. This compound exhibits broad-spectrum antimicrobial activity, effectively targeting bacteria, fungi, and some viruses. Tyrothricin is commonly used in formulations for the treatment of sore throat and the healing of infected superficial and small-area wounds, making it valuable in both clinical and research settings.

α-Terpineol is an antimicrobial compound primarily targeting periodontopathic and cariogenic bacteria. This compound demonstrates significant antifungal activity against Trichophyton mentagrophytes, potentially causing irreversible cellular damage. Additionally, α-Terpineol exhibits antineuropathic and anti-inflammatory properties, making it a valuable reagent for research involving diarrhea, neuropathic pain, infections, and inflammation.

Lomefloxacin hydrochloride is a difluoroquinolone antibiotic that primarily targets bacterial topoisomerase II, inhibiting DNA supercoiling and replication. It exhibits broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria and induces reactive oxygen species (ROS) production, leading to apoptosis. Additionally, Lomefloxacin hydrochloride demonstrates anticancer effects, particularly against melanoma, making it a valuable reagent for studying systemic bacterial infections and skin malignancies.

Novobiocin sodium is a potent antibiotic that primarily targets DNA gyrase, exhibiting significant inhibitory action in various bacterial strains. Additionally, it acts as an antagonist of heat shock protein 90 (Hsp90), expanding its potential applicability in therapeutic research. Novobiocin sodium is particularly valuable for studies on beta-lactam-resistant pneumococcal infections and demonstrates anti-orthopoxvirus activity, highlighting its relevance in infectious disease research.

Bifonazole is an imidazole antifungal agent that primarily targets fungal cell membranes. It exhibits broad-spectrum antibacterial and antifungal activity, making it effective against various dermatophytes and yeast infections. Bifonazole is utilized in research settings to study antifungal mechanisms and evaluate new therapeutic strategies for fungal infections.

Phenothiazine is an antibiotic that exhibits broad-spectrum biological activity, including insecticidal, fungicidal, antibacterial, and anthelmintic effects. Additionally, it is instrumental in research related to neurological diseases, offering insights into potential therapeutic mechanisms. This compound serves as a valuable tool for scientists studying microbial resistance and the treatment of parasitic infections.

Sulfacetamide sodium is a sulfonamide antibiotic targeting bacterial infections, primarily utilized in ocular research. It exhibits both antibacterial and antifungal activity, making it an important reagent for studying and treating various infections. Applications include investigation of microbial resistance and the efficacy of topical treatments against ocular pathogens.

Sulfacetamide sodium monohydrate is a sulfonamide antibiotic primarily targeting bacterial infections. It exhibits both antifungal and antibacterial activities, making it valuable for studying ocular infections. This reagent is useful in research applications that explore mechanisms of infection and treatment efficacy in ophthalmology.

Fluconazole hydrate is a triazole antifungal agent that targets fungal cell membrane synthesis by inhibiting the enzyme lanosterol 14-alpha-demethylase. It exhibits significant efficacy against a range of superficial and systemic fungal infections, making it a critical tool in the treatment and prevention of candidiasis and cryptococcosis. Fluconazole hydrate is widely utilized in clinical research to explore antifungal resistance mechanisms and assess therapeutic strategies in various fungal pathogens.

(S)-Dihydroaeruginoic acid is an antibiotic derived from Pseudomonas fluorescens, targeting various microbial pathogens. It exhibits substantial antimicrobial activity against a range of fungi, including Rhizoctonia solani, Phytophthora ultimum, Botrytis cinerea, Sclerotium rolfsii, Colletotrichum gloeosporioides, Fusarium oxysporum, and Septoria tritici, as well as against bacterial strains such as Bacillus subtilis, Erwinia herbicola, and Streptomyces albus when assessed at a concentration of 200 μg/disc. This compound is valuable for research focused on antibiotic development and the study of microbial resistance.

Verlamelin is a depsipeptide antibiotic that targets and disrupts cellular processes in fungi. It exhibits significant antifungal activity against various plant pathogens, making it a valuable tool for research into plant disease management and fungal biology. Its unique mechanism of action can be explored for insights into antibiotic resistance and the development of new antifungal therapies.

Mucidin is an antifungal antibiotic that primarily targets the cytochrome bc1 complex within the mitochondrial respiratory chain, inhibiting electron-transfer reactions. This mechanism disrupts ATP production in fungi, leading to their growth inhibition. Mucidin is useful in research applications focused on fungal pathogenesis and mitochondrial function, providing insights into antifungal resistance and treatment strategies.

Oudemansin A is an antibiotic that targets fungal pathogens by inhibiting protein, RNA, and DNA synthesis. This compound demonstrates significant antifungal activity, making it a valuable reagent in research focused on the mechanisms of fungal infection and resistance. Its efficacy in disrupting essential cellular processes highlights its potential for exploring new therapeutic approaches in mycology.

Pulvilloric acid is an antifungal antibiotic that specifically targets fungal pathogens. Isolated from the fungus Penicillium pulvillorum, this compound exhibits significant antimicrobial activity, making it valuable in research related to antifungal drug development and microbial resistance studies. Its unique mechanism of action positions it as a critical reagent for investigating fungal infections and developing effective therapeutic strategies.

Exfoliazone is a phenoxazine antibiotic that targets fungal organisms, specifically demonstrating efficacy against Valsa ceratosperma. This compound exhibits significant antifungal activity, with an effective dose (ED50) for inhibiting mycelial growth calculated at 70 μg/mL. It serves as a valuable tool for studying fungal resistance mechanisms and exploring potential therapeutic applications in mycology research.

Pyrrolomycin E is a pyrrole antibiotic that exhibits broad-spectrum antibacterial activity. It demonstrates efficacy against both Gram-positive and Gram-negative bacteria, as well as antifungal properties against various fungal strains. This compound is valuable for research applications focused on antibiotic resistance and the development of new antimicrobial agents.

Glidobactin F is an antitumor antibiotic known for its effectiveness against pathogenic fungi and yeast. This compound demonstrates significant anticancer activity, particularly in enhancing the survival of mice inoculated with P388 leukemia cells. Glidobactin F is valuable for research applications focused on cancer treatment and antifungal studies.

β-Prumycin hydrochloride is a carbohydrate antibiotic that exhibits antifungal activity and demonstrates limited antibacterial properties. Its primary application lies in research focused on microbial resistance mechanisms and the development of new antimicrobial therapies. β-Prumycin hydrochloride serves as a valuable tool for studying the interactions between carbohydrates and microbial organisms.

Leucomycin A5 is an antibiotic known for its antifungal activity, effectively targeting various bacterial strains. The minimum inhibitory concentration (MIC) for Staphylococcus pyogenes penicillin-sensitive is 0.8 µg/mL, while Staphylococcus pyogenes penicillin-resistant and Staphylococcus faecalis display MIC values of 3.2 µg/mL and 0.8 µg/mL, respectively. This compound is utilized in research applications focusing on bacterial resistance and the development of novel antimicrobial therapies.

Albiducin A is an antibiotic derived from the fungus Hymenoscyphus albidus, known for its antibacterial and anticancer properties. It demonstrates a minimum inhibitory concentration (MIC) range against bacteria and fungi of 16.7-66.7 mg/mL. In cellular assays, Albiducin A exhibits IC50 values of 6.1 μg/mL for mouse fibroblast L929 cells and 2.7 μg/mL for human cervical carcinoma KB3-1 cells. This compound is of significant interest for research in infection and cancer treatment.

Epoformin is a fungal cyclohexene epoxide derived from Diplodia quercivora, primarily acting as an antibiotic. It exhibits inhibitory effects on rye seedling sheath growth and demonstrates notable antifungal activity, particularly against pathogens such as Phytophthora cinnamomi and Phytophthora plurivora. Epoformin is suitable for research applications focusing on antimicrobial mechanisms and the study of plant-pathogen interactions.

Destomycin B is an antibiotic with a primary mechanism of action against fungal pathogens. This compound exhibits significant antifungal activity and also possesses anthelmintic properties, making it valuable for research focused on parasitic infections. Its unique biological activities render it an essential reagent for studies involving fungal resistance and helminthic diseases.

Aranochlor A is an antibiotic derived from the marine organism Pseudoarachniotus roseus. This compound demonstrates significant antibacterial and antifungal activities, making it a valuable reagent for research in microbiology and pharmacology. Its unique properties may contribute to studies focused on developing new antimicrobial agents and understanding resistance mechanisms in pathogens.

Arginomycin is a nucleoside antibiotic that primarily targets the growth mechanisms of Gram-positive bacteria and fungi. This compound exhibits potent antibacterial and antifungal activity, making it useful in microbiological research and the study of microbial resistance. Its ability to inhibit the proliferation of specific pathogens supports investigations into antimicrobial therapies and the development of new antibiotics.